Pfizer-BioNTech’s news on Nov.
Pfizer’s vaccine was seen bringing about a value revival, yet several waves of rotation from growth to value in the past year have proved short-lived.
The year saw global stocks add nearly $16 trillion in market capitalisation but much was down to tech, possibly as reopenings – and economic recovery – were stymied by COVID.
Sovereign bonds were among the biggest losers immediately after the vaccine news.
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day.